CD19 and diffuse large B-cell lymphoma: Adoptive transfer of CD19-targeted CAR-T cells has revolutionised treatment of relapsed/refractory B-cell acute lymphoblastic leukemia(ALL) and diffuse large B-cell lymphoma (DLBCL).